et al. et al.
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Correlates of intent to be vaccinated against human papillomavirus: an exploratory study of college-aged women

Richard Crosby A B C G , Nancy Schoenberg D , Claudia Hopenhayn A , Greg Moore A E and William Melhan F

A College of Public Health, University of Kentucky, 121 Washington Ave, Lexington, KY 40506-0003, USA.

B Rural Center for AIDS/STD Prevention, 801 East 7th St, Bloomington, IN 47405, USA.

C The Kinsey Institute for Research in Sex, Gender, and Reproduction, Indiana University, Morrison Hall, Bloomington, IN 47405, USA.

D Department of Behavioral Sciences, College of Medicine Office Building, University of Kentucky, Lexington, KY 40536-0086, USA.

E B163 Kentucky Clinic, 740 S. Limestone Dr, University of Kentucky, Lexington, KY 40536-0284, USA.

F Caudill Health Clinic, 112 Allie Young Hall, Morehead University, Morehead, KY 40351, USA.

G Corresponding author. Email: crosby@uky.edu

Sexual Health 4(1) 71-73 https://doi.org/10.1071/SH06046
Submitted: 25 July 2006  Accepted: 17 January 2007   Published: 26 February 2007

Abstract

This study identified correlates of human papillomavirus (HPV) vaccine acceptance among college-aged women. Data were collected by self-administered questionnaire. In multivariate analyses, women having vaginal sex (past 12 months) were nearly four times more likely to indicate acceptance (P = 0.0001). Those reporting ever having a sexually transmissible infection (STI; P = 0.03) and those indicating ever having an abnormal Pap test (P = 0.03) were more likely to indicate acceptance. Thus, three forms of ‘exposure’ (having sex, having an STI or abnormal Pap) may be linked to vaccine acceptance among young women attending universities. The findings suggest that opportunities may exist for clinic-based HPV vaccine promotion among this population of women.

Additional keywords: cervical cancer, prevention, sexual behaviour.


References


[1] Ries LAG , Harkins D , Krapcho M , Mariotto A , Miller BA , Feuer EJ , et al editors. SEER Cancer Statistics Review, 1975–2003. Bethesda, MD: National Cancer Institute; 2006. Available online at: http://seer.cancer.gov/csr/1975_2003/ [verified January 2007].

[2] Walboomers JMM,  Jacobs MV,  Manos MM,  Bosch FX,  Kummer JA,  Shah KV, et al. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189 12–9.
CrossRef | PubMed |

[3] Castellsague X,  Bosch FX,  Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Research 2002; 89 191–9.
CrossRef | PubMed |

[4] Koskela P,  Anttila T,  Bjorge T,  Brunsvic A,  Dillner J,  Hakama M,  Hakulinen T,  Jellum E,  Lehtinen M,  Lenner P,  Luostarinen T,  Pukkala E,  Saikku P,  Thoresen S,  Youngman L,  Paavonen J.. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000; 85 35–9.
CrossRef | PubMed |

[5] Castellsague X,  Munoz N.. Cofactors in human papillomavirus carcinogenesis – role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monographs 2003; 31: 20–8.
CrossRef | PubMed |

[6] Schiffman MH,  Castle P,  E2 Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 2003; 95 E2.
PubMed |

[7] Myers ER. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151 1158–71.
PubMed |

[8] CNN news.com. FDA approves first cervical cancer vaccine. Available online at: http://www.cnn.com/2006/HEALTH/06/08/cervical.vaccine/index.html [verified 3 July 2006].

[9] Munoz N,  Bosch FX,  de Sanjose S,  Herrero R,  Castellsague X,  Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348 518–27.
CrossRef | PubMed |

[10] Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005; 37 S17–23.
CrossRef | PubMed |

[11] Zimet GD,  Mays RM,  Fortenberry JD. Vaccines against sexually transmitted infections: promise and problems of the magic bullets for prevention and control. Sex Transm Dis 2000; 27 49–52.
CrossRef | PubMed |

[12] Kahn JA,  Rosenthal SL,  Hamann T,  Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS 2003; 14 300–6.
CrossRef | PubMed |

[13] Boehner CW,  Howe SR,  Bernstein DI,  Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003; 30 774–8.
CrossRef | PubMed |



Rent Article (via Deepdyve) Export Citation Cited By (24)